121 related articles for article (PubMed ID: 2048230)
1. Leukocyte alkaline phosphatase and carcinoembryonic antigen in metastatic colorectal cancer patients.
Walach N; Guterman A; Zaidman JL; Kaufman S; Weimberger L; Scharf S
Tumori; 1991 Apr; 77(2):164-6. PubMed ID: 2048230
[TBL] [Abstract][Full Text] [Related]
2. Leukocyte alkaline phosphatase, CA15-3, CA125, and CEA in cancer patients.
Walach N; Gur Y
Tumori; 1998; 84(3):360-3. PubMed ID: 9678617
[TBL] [Abstract][Full Text] [Related]
3. Leukocyte alkaline phosphatase and carcinoembryonic antigen in breast cancer patients: clinical correlation with the markers.
Walach N; Guterman A; Zaidman JL; Kaufman S; Scharf S
J Surg Oncol; 1989 Feb; 40(2):85-7. PubMed ID: 2915542
[TBL] [Abstract][Full Text] [Related]
4. Leukocyte alkaline phosphatase and carcinoembryonic antigen in colorectal cancer patients (usefulness in the assessment of the stage).
Walach N; Guterman A; Zaidman JL; Kaufman S; Scharf S
Oncology; 1991; 48(2):128-30. PubMed ID: 1997936
[TBL] [Abstract][Full Text] [Related]
5. Leukocyte alkaline phosphatase and carcinoembryonic antigen in lung cancer patients.
Walach N; Gur Y
Oncology; 1993; 50(4):279-84. PubMed ID: 8388558
[TBL] [Abstract][Full Text] [Related]
6. Leukocyte alkaline phosphatase and serum alkaline phosphatase in patients with metastatic breast and colon cancer.
Walach N; Gur Y
Neoplasma; 1996; 43(5):297-300. PubMed ID: 8996547
[TBL] [Abstract][Full Text] [Related]
7. Clinical impact of 18F-FDG-PET in the suspicion of recurrent colorectal cancer based on asymptomatically elevated serum level of carcinoembryonic antigen (CEA) in Taiwan.
Shen YY; Liang JA; Chen YK; Tsai CY; Kao CH
Hepatogastroenterology; 2006; 53(69):348-50. PubMed ID: 16795969
[TBL] [Abstract][Full Text] [Related]
8. Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases?
Bakalakos EA; Burak WE; Young DC; Martin EW
Am J Surg; 1999 Jan; 177(1):2-6. PubMed ID: 10037299
[TBL] [Abstract][Full Text] [Related]
9. EIA versus RIA in detecting carcinoembryonic antigen level of patients with metastatic colorectal cancer.
Wang WS; Lin JK; Lin TC; Chiou TJ; Liu JH; Yen CC; Chen WS; Jiang JK; Yang SH; Wang HS; Chen PM
Hepatogastroenterology; 2004; 51(55):136-41. PubMed ID: 15011849
[TBL] [Abstract][Full Text] [Related]
10. Leukocyte alkaline phosphatase and carcinoembryonic antigen in breast cancer patients. Influence of the treatment on the markers.
Walach N; Guterman A; Zaidman JL; Scharf S; Weinberger L; Kaufman S
Neoplasma; 1990; 37(6):627-30. PubMed ID: 2274082
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of serum carcinoembryonic antigen monitoring in the follow-up of colorectal cancer patients with metastatic lymph nodes and a normal preoperative serum level.
Tobaruela E; Enriquez JM; Diez M; Camunas J; Muguerza J; Granell J
Int J Biol Markers; 1997; 12(1):18-21. PubMed ID: 9176713
[TBL] [Abstract][Full Text] [Related]
12. Screening for liver metastases from colorectal cancer with carcinoembryonic antigen and alkaline phosphatase.
Tartter PI; Slater G; Gelernt I; Aufses AH
Ann Surg; 1981 Mar; 193(3):357-60. PubMed ID: 7212797
[TBL] [Abstract][Full Text] [Related]
13. Serum carbohydrate antigen 19-9 as an indicator of liver metastasis in colorectal carcinoma cases.
Dong H; Tang J; Li LH; Ge J; Chen X; Ding J; Men HT; Luo WX; Du Y; Li C; Zhao F; Chen Y; Cheng K; Liu JY
Asian Pac J Cancer Prev; 2013; 14(2):909-13. PubMed ID: 23621260
[TBL] [Abstract][Full Text] [Related]
14. High-molecular-mass alkaline phosphatase as a tumor marker for colorectal cancer: comparison of two test methods.
Wei JS; Chung NC; Wei LL; Tzeng WF; Liu TZ; Wang JY
Clin Chem; 1993 Mar; 39(3):540-3. PubMed ID: 8448874
[TBL] [Abstract][Full Text] [Related]
15. Individual cutoff levels of carcinoembryonic antigen and CA 242 indicate recurrence of colorectal cancer with high sensitivity.
Engarås B
Dis Colon Rectum; 2003 Mar; 46(3):313-21. PubMed ID: 12626905
[TBL] [Abstract][Full Text] [Related]
16. Relevance of CEA and LDH in relation to KRAS status in patients with unresectable colorectal liver metastases.
Connell LC; Boucher TM; Chou JF; Capanu M; Maldonado S; Kemeny NE
J Surg Oncol; 2017 Mar; 115(4):480-487. PubMed ID: 28008623
[TBL] [Abstract][Full Text] [Related]
17. Technical surgical considerations for CEA directed second-look operations and hepatic tumor excision.
Minton JP
Semin Surg Oncol; 1991; 7(3):143-5. PubMed ID: 2068447
[TBL] [Abstract][Full Text] [Related]
18. Improved tumour marker sensitivity in detecting colorectal liver metastases by combined type IV collagen and CEA measurement.
Nyström H; Tavelin B; Björklund M; Naredi P; Sund M
Tumour Biol; 2015 Dec; 36(12):9839-47. PubMed ID: 26162539
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum YKL-40, IL-6, CRP, CEA, and CA19-9 combined as a prognostic biomarker panel after resection of colorectal liver metastases.
Peltonen R; Gramkow MH; Dehlendorff C; Osterlund PJ; Johansen JS; Isoniemi H
PLoS One; 2020; 15(8):e0236569. PubMed ID: 32756596
[TBL] [Abstract][Full Text] [Related]
20. Can biliary carcinoembryonic antigen identify colorectal cancer patients with occult hepatic metastases?
Li Destri G; Lanteri R; Santangelo M; Torrisi B; Di Cataldo A; Puleo S
World J Surg; 2006 Aug; 30(8):1494-9. PubMed ID: 16847713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
